Understanding PTEN in Cancer

The role of PTEN feedback mechanism in cancer

NIH-funded research University of Tx Md Anderson Can Ctr · NIH-11074122

This project explores how a key protein called PTEN works in cancer cells to help us find new ways to fight the disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-11074122 on NIH RePORTER

What this research studies

Our bodies have a protein called PTEN that acts like a brake on cancer growth, but it often gets changed in human cancers. This project looks at how small changes to PTEN, called post-translational modifications, affect its ability to stop cancer. We are also exploring how PTEN works beyond its main pathway, including its role in keeping our genes stable and controlling cell division. By understanding these detailed mechanisms, we hope to uncover new targets for cancer treatments.

Who could benefit from this research

Good fit: This foundational research is not recruiting patients directly but aims to benefit future patients with various cancers by improving our understanding of disease mechanisms.

Not a fit: Patients seeking immediate treatment options will not directly benefit from this basic science research.

Why it matters

Potential benefit: If successful, this work could lead to new strategies for cancer treatment by targeting how PTEN functions in tumor cells.

How similar studies have performed: Previous studies, including work by this team, have shown that changes to PTEN can lead to cancer, and this project builds upon that established knowledge with novel investigations.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer PatientCancer Suppressor GenesCancers
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.